Fortune 40: Stock picks to retire on

Forty stock picks inspired by the greatest investors of all-time: From the deepest values to solid growth, these shares can make retirement dreams come true.

WYE: The numbers
Market Cap $76.7 billion
Total Return YTD (June 11) 12.9%
Total Return Last 12 Months 30.8%
Earnings Growth (Next Five Years) 7.0%
P/E (Pasts 12 months) 17.6
P/E (Next Year's Estimate) 14.7
Dividend Yield 1.8%
Source: Baseline, as of June 11, 2007.
Growth and Income
Wyeth
Its blockbuster drugs treat a wide range of conditions, and it has an equally broad pipeline. Wyeth has one of the most successful vaccines on the market, the fast-growing Prevnar to prevent pneumonia in children.

The company also shares a shelf with Novartis as a pharma-biotech hybrid, meaning it can balance the risk of a fast-growing industry (biotech) with the stability of a slow-growing business (pharma.) Wyeth's 90-acre Grange Castle in Ireland is said to be the biggest biotech plant in the world, putting it on a par with pure-play biotech industry leaders Amgen and Genentech.
Abbott Labs Johnson & Johnson Coca-Cola Altria Group Colgate General Mills Procter & Gamble Wyeth Accenture AIG Chubb ConocoPhillips McKesson 3M Microsoft United Health Pfizer Aetna Applied Industrial Carpenter Technology Loews Lufkin Tidewater VF Corp. Grey Wolf CSG Systems Hercules K-Swiss Navigant Consulting Park Electrochemical Penn Virginia Plexus UBS Diageo Novartis Petroleo Brasileiro Sanofi-Aventis Total Unilever Vodafone
Bargain hunting for condos The real estate slowdown has made parts of the Sunbelt a lot more affordable. Fortune presents a guide to finding the best deals in five markets. (more)
Retired at 50 Is it possible for someone who doesn't run a hedge fund or win the lottery to retire at 50 (or so)? Yes. (more)
Retirement: Now what?! Think you know what will make you happy? Learn from those who've been there, done that. (more)